Research Article

Mycobacterium tuberculosis Infection following Kidney Transplantation

Table 4

Anti-TB treatment and course of patients.

NameDuration of ttt TB treatment (months)Course Recurrence of TB Interval between stop of TB ttt and recurrence Duration of resumption of antiTB treatment (months)Followup (months)Course

(1) A M6ARF, DCG loss of graftLumbar pain and radiologic abnormalities 12 9,363HD
(2) A H12Hepatotoxicity hyperuricemiaLymph nodes TB12 213,717Recovery
(3) Z A12ARF CAD11,992HD
(4) Gh N12Meningeal and vertebral TB after stop of ttt23,918Death
(5) D Y10ARF, CAD26,809CAD
(6) H O121,150Recovery
(7) D M6HepatotoxicityLymph nodes TB, 6 months after stop of ttt12 149,881Recovery
(8) H A12ARF20,337Recovery
(9) M A10Hepatotoxicity Hyperuricemia58,251Recovery
(10) M F1CAD1,577Death
(11) H Dh99,626Recovery
(12) M A12Hyperuricemia16,657Recovery
(13) J K12ARF CAD35,055CAD
(14) Ch N12CAD 47,441HD
(15) B F17ARF173,602Recovery
(16) J H10Hyperuricemia ARF CAD18,201HD

ARF: acute renal failure, AR: acute rejection, CAD: chronic allograft dysfunction, HD: hemodialysis, ttt: TB treatment, TB: tuberculosis.